AIM ImmunoTech Announces Expiration and Preliminary Results of its Rights Offering for Aggregate Gross Proceeds of $1.8 Million
March 4, 2026
March 4, 2026
March 4, 2026
March 4, 2026
March 4, 2026
March 4, 2026
March 4, 2026
March 4, 2026
March 4, 2026
March 4, 2026
March 3, 2026
March 3, 2026
March 3, 2026
March 3, 2026
March 3, 2026
March 3, 2026
March 2, 2026